Synopsys sells the software that chip engineers cannot work without. When a company wants to design a new chip, it needs tools to plan the circuit, test that it works, and prepare it for manufacturing. Synopsys provides those tools, plus pre-built circuit blocks called Design IP that engineers drop into their chips to save time, and now also simulation software from Ansys that lets engineers test how physical products behave before building them. Most of the software is licensed through multi-year subscription contracts, meaning customers pay regularly over two to three years rather than once, which creates a steady stream of income. The diagram below traces where the money goes.
How Synopsys Makes Money
flowchart LR
A["Customer R&D Teams
Semiconductor & Systems"] --> B["License EDA Software
$5.1B Revenue"]
A --> C["License Design IP
Pre-built Chip Blocks"]
A --> D["Subscribe Ansys S&A
Simulation & Analysis"]
B --> E["Design Productivity
Faster Time to Market"]
C --> E
D --> E
E --> F["Customer Product Success
Chips & Systems Built"]
F --> G["Recurring License Fees
Maintenance & Updates
$1.6B Revenue"]
G --> B
B --> H["R&D Investment
New AI Tools & Features"]
C --> H
D --> H
H --> I["Synopsys.ai Suite
AI-Driven Optimization"]
I --> E
G --> J["Operating Cash Flow
$1.5B"]
J --> H
Five years of financial data tell a clear story about direction. Revenue grew from $4.2 billion in 2021 to $7.1 billion in 2025, a run that held even when the broader semiconductor industry had rough patches. Gross margins stayed impressively stable, hovering around 80% from 2021 through 2023, which reflects how software-heavy this business is. Making one more copy of software costs almost nothing extra.
Annual Revenue (2021 to 2025)
Revenue in billions of dollars. The 2025 jump includes $756.6 million from the Ansys acquisition, which closed in July 2025.
The revenue growth looks strong, but two things shifted underneath in 2025. First, gross margin dipped from roughly 80% to about 77%, partly because the Ansys business carries different cost structures. Second, net debt flipped from a comfortable net cash position to $10.6 billion of net debt, because Synopsys borrowed about $13.5 billion to pay for Ansys. Free cash flow, which had been rising steadily, held at $1.3 billion in 2025 but now has to service a much larger debt load.
$1.4B cash surplus
Net cash position (2024)
$10.6B debt
Net debt position (2025)
The Ansys deal, which closed July 2025, transformed the balance sheet in a single year.
Despite strong headline revenue, not everything moved in the right direction in 2025. The Design IP segment, which sells pre-built circuit blocks, actually shrank by 8% compared to 2024. Three problems hit at once: US export control rules disrupted chip design starts in China, a major foundry customer pulled back spending, and some internal product decisions did not deliver as planned. China revenue, excluding Ansys, fell 22% compared to 2024. This matters because China is a large market for chip design software.
$11.4B
Contracted backlog as of October 2025, up from $8.1B a year earlier, future revenue already committed by customers
The backlog figure shows that customers are still committing to multi-year deals even while some are delaying purchases in the near term. About 45% of that backlog is expected to convert to revenue within the next 12 months. The subscription model means today's signed contracts become tomorrow's recognised revenue, which is why short-term demand slowdowns take time to show up fully in the income statement. That same delay works in reverse when conditions improve.
What are export controls and why do they matter here?
The US government restricts what technology companies can sell to certain countries. For chip design software, these rules can prevent Synopsys from selling specific tools to Chinese customers. In May 2025, Synopsys received a government letter imposing new license requirements for sales of certain software to China. That letter was later rescinded in July 2025, but the uncertainty alone disrupted customer decisions and hurt revenue. Rules like this can change again at any time.
The risks documented in the company's own filings are concrete and specific. The US government's export rules keep changing, and Synopsys has already received formal notices from the Bureau of Industry and Security about sales to Chinese companies. A small number of large customers provide a significant share of revenue, and one major foundry customer already pulled back in 2025, directly hurting results. Then there is the Ansys debt. Borrowing $13.5 billion to buy a company means the combined business must perform well enough to pay down that debt while still investing in products.
2025
milestone
Ansys Merger Closes
In July 2025, Synopsys completed its acquisition of Ansys, adding simulation software used across aerospace, automotive, healthcare and many other industries. The deal added $756.6 million in revenue in just the portion of 2025 after closing, brought total employees to roughly 28,000, and extended Synopsys from pure chip design tools into a much broader engineering software platform. It also added $13.5 billion in debt.
The Ansys deal is the defining question for the next several years. Synopsys is now a larger, more complex company serving aerospace engineers, automotive designers and healthcare researchers, not just chip makers. If customers in those new industries adopt Ansys tools at the pace Synopsys expects, the combined revenue base justifies the debt. If they do not, free cash flow of $1.3 billion per year faces a significant debt servicing burden with less room for error.
77%
Gross margin in fiscal 2025, down from roughly 80% in 2021 to 2023, reflecting the cost structure of the newly added Ansys business
Why the chip design software market is hard to enter
Synopsys, Cadence Design Systems and Siemens EDA together control about 75% of the global market for electronic design automation software. Engineers spend years learning these tools, and chip designs are built around specific software workflows. Switching to a different vendor mid-project is extremely disruptive. This makes it very hard for new competitors to win customers away, but it also means the three incumbents compete intensely for the same pool of spending.
On the competitive side, artificial intelligence is changing how chip design software works. Synopsys has released its Synopsys.ai suite, which uses AI to speed up tasks that engineers used to do manually, like optimising chip layouts and testing for errors. If AI makes the design process faster, customers may need fewer hours of software per chip, which could change how much they pay. Alternatively, faster design could mean more chips get designed, which would increase overall demand for tools. The direction of that effect is not yet clear.
Synopsys holds more than 3,800 issued US and foreign patents, with expiration dates extending through 2044. The business explicitly states it is not significantly dependent on any single patent, which suggests the competitive position rests more on accumulated know-how and customer relationships than on any one piece of protected technology.
The Bet
Synopsys borrowed $13.5 billion on the assumption that Ansys customers across aerospace, automotive, healthcare and industrial engineering will deepen their spending on simulation software over the next several years, and that the combined revenue of a silicon-to-systems platform will grow fast enough to comfortably service that debt while margins recover toward prior levels. If the Ansys integration stumbles, if China restrictions tighten further and cut a meaningful slice of the chip design market, or if the new industries Synopsys entered prove slower to spend than expected, the debt burden becomes the dominant story rather than the growth story.
Open question
The Design IP segment shrank 8% in 2025, China revenue fell 22% excluding Ansys, gross margins compressed, and net debt went from a $1.4 billion surplus to $10.6 billion of obligations, all in a single year. At the same time, the backlog grew to $11.4 billion, the core EDA business kept expanding, and Synopsys now sits at the centre of both AI chip design and broad engineering simulation. Can the Ansys revenue engine grow fast enough, across enough new industries, to justify $13.5 billion of borrowed money, while the China export control situation and Design IP weakness resolve, and before the debt load starts to constrain what the combined company can do next?
Compiled · 10-K · FY2025
Trade Restrictions and Export Controls
The U.S. government restricts what products this company can sell to certain countries and customers, especially China. The company has received legal requests from the Bureau of Industry and Security about sales to Chinese companies, and new trade rules keep changing, which could prevent the company from selling its products globally or to major customers.
Customer Concentration and Foundry Dependency
A small number of large customers provide most of this company's revenue, and problems with one major foundry customer already hurt their financial results in 2025. If these big customers reduce spending, merge with competitors, or develop their own tools instead of buying from this company, revenue could drop significantly.
Ansys Merger Integration and Debt
The company borrowed about 13.5 billion dollars to buy Ansys in July 2025 and must now pay back this large debt. If the combined company does not perform as expected, if the integration fails, or if cash flow drops, the company may struggle to make debt payments and could face serious financial problems.
Macroeconomic and Geopolitical Uncertainty
Tariffs, trade tensions between the U.S. and China, supply chain disruptions, and economic slowdowns are making customers delay purchases and reduce spending on design tools. If these conditions worsen or persist, demand for the company's products could fall sharply and revenue could decline significantly.
AI Technology Development and Market Risk
The company is investing heavily in artificial intelligence features for its products, but if competitors develop AI tools faster or better, or if laws and copyright rules around AI change in unfavorable ways, the company could lose its competitive advantage. Emerging AI markets may also develop slower than expected, reducing potential growth.
10-K Item 1A · Risk Factors
